Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNYNF) Invested Capital (2016 - 2025)

Historic Invested Capital for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $105.3 billion.

  • Sanofi's Invested Capital rose 479.04% to $105.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $105.3 billion, marking a year-over-year increase of 479.04%. This contributed to the annual value of $102.2 billion for FY2025, which is 43.4% up from last year.
  • Per Sanofi's latest filing, its Invested Capital stood at $105.3 billion for Q4 2025, which was up 479.04% from $87.8 billion recorded in Q2 2025.
  • In the past 5 years, Sanofi's Invested Capital ranged from a high of $105.3 billion in Q4 2025 and a low of $5.7 billion during Q2 2021
  • In the last 5 years, Sanofi's Invested Capital had a median value of $92.2 billion in 2022 and averaged $84.7 billion.
  • As far as peak fluctuations go, Sanofi's Invested Capital tumbled by 9223.21% in 2021, and later surged by 128811.06% in 2022.
  • Over the past 5 years, Sanofi's Invested Capital (Quarter) stood at $101.7 billion in 2021, then decreased by 5.73% to $95.9 billion in 2022, then grew by 1.96% to $97.8 billion in 2023, then increased by 2.72% to $100.4 billion in 2024, then grew by 4.79% to $105.3 billion in 2025.
  • Its last three reported values are $105.3 billion in Q4 2025, $87.8 billion for Q2 2025, and $100.4 billion during Q4 2024.